{
    "id": "dbpedia_6784_2",
    "rank": 69,
    "data": {
        "url": "https://sljid.sljol.info/about/submissions",
        "read_more_link": "",
        "language": "en",
        "title": "Sri Lankan Journal of Infectious Diseases",
        "top_image": "https://storage.googleapis.com/jnl-sljo-j-sljid-public/journals/1/journalThumbnail_en_US.jpg",
        "meta_img": "https://storage.googleapis.com/jnl-sljo-j-sljid-public/journals/1/journalThumbnail_en_US.jpg",
        "images": [
            "https://www.journalquality.info/journalquality/img/2.png",
            "https://storage.googleapis.com/jnl-sljo-j-sljid-public/journals/1/pressLogoImage_en_US.png?t=1723864020000",
            "https://i.creativecommons.org/l/by/4.0/88x31.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The Sri Lankan Journal of Infectious Diseases (SLJID) is an open access, peer-reviewed, biannual journal published by the Sri Lankan Society for Microbiology (SSM). The Journal considers articles from all professional disciplines involved in the field of infectious diseases in humans.  The Journal has been in publication since 2011, is included in the DOAJ since 2018 and is a member of COPE since 2021. The SLJID practices a double-blind peer review policy. From 2022, the SLJID publishes accepted manuscripts online immediately after copy-editing, enabling rapid dissemination of scientific knowledge. The published articles are subsequently compiled into two issues in April and October. The SLJID does not charge any article processing or publication fee.",
        "meta_lang": "en",
        "meta_favicon": "https://storage.googleapis.com/jnl-sljo-j-sljid-public/journals/1/favicon_en_US.png",
        "meta_site_name": "Sri Lankan Journal of Infectious Diseases",
        "canonical_link": "https://sljid.sljol.info/about/authorship",
        "text": "Authors are encouraged to go through this section and the sections titled Focus and Scope and Research Integrity before submitting any manuscript to the SLJID.\n\nTypes of Articles\n\nLeading Articles\n\nExpert opinions on current topics or commentaries on papers published in SLJID. These are solicited by the Editors.\n\nNumber of words <1500, key references<20, no tables or illustrations,\n\nnon-structured abstract of 150 words.\n\nSystematic Reviews and meta-analysis\n\nSystematic summary of available evidence. Would be subjected to review by a statistician in addition to content experts.\n\nNumber of words <3000, references <70, structured abstract of <250 words (introduction, methods, results, conclusions), keywords 3–5, Tables and Figures <5 (if more, discuss with the Editor).\n\nNarrative Reviews\n\nProvides the reader with a comprehensive overview of an important subject and should be systematic with critical assessment of the literature.\n\nNumber of words <3000, references <50, unstructured abstract of <250 words, keywords 3-5 Tables and Figures <5.\n\nMini Reviews\n\nProvides a concise summary on recent advances on a specific topic.\n\nNumber of words <1500, references <30, unstructured abstract of <150 words, keywords 3-5 Tables and Figures <5.\n\nResearch Articles\n\nScientific reports of the results of original research. Manuscript should follow the IMRAD (Introduction, Methods, Results and Discussion) format.\n\nNumber of words <2500, references <20, structured abstract of <250 words(introduction, methods, results, conclusions), keywords 3-5, Tables and Figures <5 (if more, discuss with the Editor).\n\nBrief Reports\n\nOriginal research that is not sufficient for full paper, secondary analysis of previously published data or preliminary results of ongoing research.\n\nNumber of words <1000, references <10, unstructured abstract of <150 words, Tables or Figures <2.\n\nCase Reports\n\nShort discussions of a clinical case that makes an important scientific observation or makes a useful contribution to the recognition, management or prevention of an infectious disease. Should include an abstract, a brief introduction, description of case report (inclusion of a timeline is a must) and a discussion. Authors need to refer to the CARE guideline and ensure it is followed.\n\nNumber of words <1000 words, references <10, unstructured abstract of <150 words, Tables or Figures <3.\n\nCase series\n\nIf more than 2 cases are being presented, they should be submitted as a case series.\n\nShould include an abstract, a brief introduction, description of case reports and a discussion. Authors need to refer to the CARE guideline and ensure it is followed.\n\nNumber of words <2500, references <15, unstructured abstract <150 words, Tables or Figures <5.\n\nPerspectives\n\nExpress opinions, present hypotheses, broach controversial issues or present new advances in infectious diseases. Number of words <1000, references <20, Tables or Figures <3, unstructured abstract < 150 words.\n\nLetters to the Editor\n\nA response to a recently published article or a short, freestanding piece expressing an opinion.\n\nNumber of words <400 words, references <5, Less than 3 authors.\n\nPreprints\n\nSLJID allows authors to submit pre-prints to repositories. Authors need to declare it in the author declaration form.\n\nSubmission of Manuscript\n\nThe following documents should be uploaded separately:\n\nAuthor declaration form (as supplementary material)\n\nTitle Page (as supplementary material)\n\nManuscript\n\nAuthor declaration form\n\nAuthor declaration form in pdf/jpg format with signatures of all authors MUST accompany all submissions.\n\nThe author declaration form should\n\nconfirm that the submission has not been previously published nor been submitted to another journal for consideration concurrently\n\ndeclare whether a preprint has been submitted to a preprint server\n\nconfirm that all authors have read the Research Integrity section of the journal website\n\nconfirm that the authors have declared any potential conflicts of interest as defined under the Research Integrity section of the journal website\n\nconfirm that all authors fulfilling criteria for authorship as defined under the Research Integrity section of the journal website have been included as authors and that author contributions have been listed\n\nstate that ethics approval and consent for participation and publication have been obtained as appropriate\n\nconfirm that all authors have read and approved the version of article being uploaded\n\ncontain the original signatures of all authors (e-signatures are acceptable and should be collated to a single document)\n\nTitle Page (use provided form)\n\nMust be in MS Word format and must include\n\nTitle of submission\n\nRunning title (less than 50 characters)\n\nMaximum of 5 keywords\n\nList authors’ names as surname and initials exactly as they are in the metadata. Authors should be listed in the order in which they are to appear in the published article.\n\nInstitutional affiliation for each author and e mail address. The institutions listed should reflect the affiliations of the authors at the time of the study, not their present affiliations, if they differ\n\nORCID identifiers of all authors\n\nName, address, e-mail address, telephone number and ORCID identifier of the corresponding author are essential\n\nConflict of Interest statement\n\nAcknowledgments / Funding source - source(s) of support / funding\n\nEthics statement and consent for publication\n\nAuthor contributions\n\nNumber of words in the manuscript excluding abstract, acknowledgments, references, tables, figures and figure legends\n\nManuscript\n\nThe manuscript document should include\n\nTitle\n\nAbstract (when applicable)\n\nKeywords\n\nMain text - sections as appropriate for type of article\n\nFigures and tables at the appropriate place\n\nStatement on conflict of interest\n\nEthics statement\n\nAcknowledgements / Funding source\n\nStatement on author contributions\n\nReferences\n\nPreparation of Manuscript\n\nThe submission file should be in Microsoft Word document file format. The computer language must be set to English (UK) and use Font Times New Roman Font size 12\n\nAll parts of the manuscript, including tables and figure legends, must be typed with single spacing\n\nDo not number the pages\n\nTables and Figures\n\nShould be clear and accurate and should not contain excessive data\n\nFigures or tables which exceed more than 1 page in length need to be uploaded separately as supplementary material\n\nOther tables and figures need to be placed within the manuscript at the appropriate plac\n\nPhotographs should be anonymized /be unidentifiable\n\nEditors may request authors to submit the original figures/illustrations and authors should be prepared to do so\n\nCopyright of copied or adapted figures and tables needs to be included beneath the figure or table\n\nNomenclature of microorganisms\n\nItalicized binary names (genus/species - for example, Staphylococcus aureus) must be used for all microorganisms at first time of use. Thereafter, the genus name should be abbreviated to the initial capital letter (for example, E. coli).\n\nNames of categories above the genus level may be used alone (for example, Enterobacterales) but specific and subspecific epithets may not.\n\nIf species are either not known or typed, the genus name should be followed by 'sp.' (for example, Neisseria sp.)\n\nInstruments or commercial test kits: Refer to by proprietary name, give name and location of the manufacturer in the text in parentheses. E.g “E strips (AB bioMerieux, Solna, Sweden) of meropenem, imipenem, ……...”\n\nAbbreviations and symbols:\n\nUse only standard abbreviations\n\nAvoid abbreviations in the title of the manuscript.\n\nThe spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention except for a standard unit of measurement. E.g. The minimum inhibitory concentration (MIC) of an antibiotic is useful to decide on specific treatment and several methods of detecting MIC are in current use.\n\nUnits of Measurement\n\nMeasurements of length, height, weight and volume should be reported in metric units (metre, kilogram or litre) or their decimal multiples or fractions. Temperatures should be in degrees Celsius. Blood pressures should be in millimetres of mercury.\n\nDrugs: Generic (nonproprietary) names should be used for all drugs. When proprietary brands are used in research, include the brand (proprietary or trade) name and the name of manufacturer in parentheses after the first mention of the generic name in the Methods section. Thereafter the generic name should be used.\n\nConflict of Interest Statement\n\nThe Sri Lankan Journal of Infectious Diseases requires that all authors declare any relevant financial and non-financial conflicts of interest.\n\nA subheading \"Conflicts of Interest\" where all authors must disclose any financial and personal relationships with people or organizations that could inappropriately influence (bias) their work, should be placed in the title page and just after the manuscript text\n\nAll funding sources of the research should be declared and published.\n\nIf there are no conflicts of interest, state \"There are no conflicts of interest\".\n\nEthics Statement\n\nA subheading \"Ethics Statement\" should accompany all research articles, case reports and case series as appropriate. This should be placed after the conflict of interest statement\n\nThis should mention from where ethics approval was obtained or if consent for publication of case reports/series was obtained from patients\n\nFor more details, please refer to the section on research integrity\n\nAcknowledgements / Funding source\n\nAll sources of funding and other support should be declared under Acknowledgments in the Title page as well as just below the main text\n\nAuthor contributions\n\nAuthorship – the SLJID subscribes to the criteria for authorship as outlined by the International Committee of Medical Journal Editors. Please refer to the linked Research Integrity section for further information\n\nAll author contributions must be identified by including abbreviated name of author followed by mentioning of his/her contributions in brief\n\nReferencing Format\n\nReferencing format for Journal\n\nCite consecutively in the text using Arabic numbers in superscript\n\nList in numerical order at the end of the manuscript\n\nAll references should be in lower case with first letters of authors’ names and journal names in upper case\n\nList all authors where there are three or less, when more than 4 authors, list the first 3 followed by ‘et al’\n\nAbbreviate Journal name according to style of PubMed. Journal name should be in italics.\n\nWhere available, provide DOI or URL for each reference doi’s can be obtained from https://www.crossref.org/guestquery (the doi is written in italics as follows: doi: https://doi.org/10.1128/JCM .02430-16 (not DOI and not underlined). If a doi is not present, include the PMID, URL or state “No doi”.\n\nExamples\n\nJournals:\n\nBoteju G, Weerasinghe G, Gunasekara H et al. Effectiveness of commonly used high level disinfectants on bacteria responsible for hospital acquired infections in Sri Jayewardenepura General Hospital, Sri Lanka. Sri Lankan Journal of Infectious Diseases 2020;10(1): 38–47. https://doi.org/10.4038/sljid.v10i1.8257\n\nBooks:\n\nJohn E. Bennett, Raphael Dolin, Martin J. Blaser (eds). Mandell, Douglas, And Bennett's Principles and Practice of Infectious Diseases. Philadelphia, PA :Elsevier/Saunders, 2015.\n\nChapter in Books:\n\nLynch P. Epidemiology and surveillance. In: Axnick KJ and Yarbrough M (eds). Infection Control, An Integrated Approach. St Louis: CV Mosby, 1984: pp 83-118.\n\nWeb-sources\n\nEpidemiology Unit, Ministry of Health, Sri Lanka. Weekly Epidemiological Reports. Available at: http://www.epid.gov.lk/web/index.php?option=com_content&view=article&id=148&Itemid=449&lang=en. Accessed on 14.07.2019\n\nUnpublished Work:\n\nPersonal communication may be cited by inserting “personal communication” in parentheses in the text; authors must submit a letter of permission from the cited persons to cite such communications.\n\nPeer Review Process\n\nYour article will be submitted to double blind peer-review after initial review by the editors. More details on the review process can be found here\n\nEditorial correspondence\n\nAddress all editorial correspondence to: slj.infectiousdiseases@gmail. com"
    }
}